Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients

NCT00240747 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00240747
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00240747 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2000
Completion date
January 31, 2005
Enrollment
Not reported
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gram-positive bacterial infections